To provide the information your oncologist is not telling you or doesn't have the time to!
Gene Therapy: A Promising Future As I continue to highlight key aspects of SCD this September, I will shift the focus to the exciting advancements in research and treatment. Recent breakthroughs offer new hope and possibilities for individuals living with this condition. In this installment, we’ll explore the latest research developments, including innovative therapies and …
Sickle Cell Disease Treatment Options In the previous post, I explored the fundamental aspects of SCD, from its genetic basis to the everyday challenges faced by those living with this condition. As I continue this journey, I will dive deeper into the current treatment options available for managing SCD and how these approaches can improve …
Sickle Cell Disease Awareness September is Sickle Cell Awareness Month, a time dedicated to shedding light on a condition that affects millions worldwide, including more than 100,000 people in the United States alone—90% of whom are African American. People with sickle cell disease face significant health challenges, with a life expectancy that is, on average, …
As I prepare to close this chapter of my life, winding down my clinic and stepping away from my role as a medical oncologist, I find myself navigating a complex mix of emotions—gratitude, sadness, and a quiet sense of anticipation. For the first time in my career, I am saying goodbye to patients and colleagues …
A recent article published in the New England Journal of Medicine (NEJM) demonstrated higher response, longer progression free survival and overall survival in patients with unresectable or metastatic leiomyosarcoma. A treatment protocol that we’ve been doing for at least 1-2 years prior given the known higher response rate reported at conferences. This is a new …
The Development of Targeted Therapy The development of targeted therapies over the past 20 years has significantly changed how we treat cancer. These therapies are designed to focus on specific molecules that help cancer cells grow and survive. By targeting these exact processes, targeted therapies provide a more personalized approach to treatment, often working better …
A Difficult Choice: Hope vs. Quality of Life James is a 62-year-old patient with advanced pancreatic cancer. After enduring multiple rounds of chemotherapy, he finds himself at a crossroads. His oncologist presents him with an option: a new experimental treatment offered through a clinical trial. This treatment carries the potential to extend his life by …
Ethan’s New Reality At 24, Ethan was excited about his future—finishing college, starting his dream job, and maybe even finding love. But everything changed when he was diagnosed with Stage II Hodgkin’s lymphoma. The news hit hard. Ethan felt overwhelmed by fear and uncertainty, worrying about his studies, job, and future plans. His vibrant future …
EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) EGFR (epidermal growth factor receptor) is a protein located on the surface of cells that regulates their growth and division. Mutations in the EGFR gene can lead to uncontrolled cell growth and are commonly found in various cancers, including non-small cell lung cancer (NSCLC). In patients with unresectable stage …
In the ever-evolving landscape of cancer care, the role of the oncology nurse navigator has emerged as a cornerstone of patient support and care coordination. In this post, we’ll explore the origins of oncology navigation, emerging trends, and what the future holds. We will also include some significant changes in billing practices that are on …